Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer
1861.2000 12.70 (0.69%)
NSE Feb 26, 2026 15:31 PM
Volume: 143.1K
 

logo
Gland Pharma Ltd.
29 Jan 2026
1861.20
0.69%
buy
by Axis Direct
Target: 2170 | Upside : 16.6%
Axis Direct
We maintain our BUY rating on the stock.
 
Number of FII/FPI investors decreased from 260 to 236 in Dec 2025 qtr
More from Gland Pharma Ltd.
Recommended
Profit expectations across industries grow more sensitive to costs
The Baseline | 26 Feb 2026, 06:30PM
We tracked 5 years of IPOs. Some hard truths for investors about returns
The Baseline | 26 Feb 2026, 04:43PM
Gland Pharma IPO: A Chinese-owned pharmaceutical company hits the IPO market
| 12 Nov 2020